The antiviral drug development research team, including the director of our center, Professor Hirofumi Sawa, and Visiting Professor Akihiko Sato, were featured in the 2024 edition of Science Translational Medicine as a Japanese Scientist in Science Translational Medicine. For more information, please click here.

※Reprinted with permission from AAAS.